Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX Showing element 2958 to 3007 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LEUCINE-RICH REPEAT PROTEIN SHOC-2 (RAS-BINDING PROTEIN SUR-8). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.100774\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.689453\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.146165148\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SHOC2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FRMPD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2 (RALGDS-LIKE FACTOR) (RAS-ASSOCIATED PROTEIN RAB2L). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0746316\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.510598\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.146165085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSFORMING PROTEIN P21/H-RAS-1 (C-H-RAS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.223524\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.52927\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.146163856\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HRAS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSFORMING PROTEIN N-RAS. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.217355\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.48707\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.146163261\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEPTIN 1 (LARP) (SEROLOGICALLY DEFINED BREAST CANCER ANTIGEN NY-BR- 24). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0798252\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.547429\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.145818362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEPT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FORKHEAD BOX PROTEIN P3 (ZINC FINGER PROTEIN JM2) (SCURFIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.193703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.33367\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.145240577\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FORKHEAD BOX PROTEIN P1 (HSPC215). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.137759\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.94872\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.145205118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FORKHEAD BOX P4; FORK HEAD-RELATED PROTEIN LIKE A; WINGED-HELIX REPRESSOR FOXP4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.136683\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.941317\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.145204007\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXP4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR (RALGEF) (RALGDS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122631\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.850955\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.144109853\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RALGDS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1 (RALGDS-LIKE 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.106453\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.742944\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.143285362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RGL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COATOMER EPSILON SUBUNIT (EPSILON-COAT PROTEIN) (EPSILON-COP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.148933\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.04237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.142879208\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COPE\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.104104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.735452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.141551046\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RIBC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBULIN-SPECIFIC CHAPERONE C (TUBULIN-FOLDING COFACTOR C) (CFC). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0292681\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.208597\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.140309305\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBCC\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DEAD-BOX PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
DDX43\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE ACYL-COA THIOESTER HYDROLASE CGI-16 (EC 3.1.2.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.231971\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.65329\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.140308718\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACOT9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-D4 (HOX-4B) (HOX-5.1) (HHO.C13). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311395\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.223127\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559533\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C5 (HOX-3D) (CP11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0320568\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.2297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559425\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXC5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C4 (HOX-3E) (CP19). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311872\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.223469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559402\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RETINAL SHORT-CHAIN DEHYDROGENASE/REDUCTASE 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.518329\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.71404\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559348\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSD17B14\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C6 (HOX-3C) (HHO.C8) (CP25). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0308655\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.221164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559332\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-B5 (HOX-2A) (HHO.C10) (HU-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.035571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.254881\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559245\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXB5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-A5 (HOX-1C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0421586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.302084\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXA5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0398119\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.285269\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559153\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTERFD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-B4 (HOX-2F) (HOX-2.6). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0313539\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.224664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559075\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXB4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-A4 (HOX-1D) (HOX-1.4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0310799\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.222701\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.13955887\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPERMATOGENESIS ASSOCIATED 6. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.107787\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.77996\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.138195548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPATA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"BETA-ARRESTIN 1 (ARRESTIN, BETA 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.282189\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04196\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.138195165\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARRB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMP DEAMINASE 2 (EC 3.5.4.6) (AMP DEAMINASE ISOFORM L). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.138195\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.138195\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
AMPD2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
C9orf68\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"BETA-ARRESTIN 2 (ARRESTIN, BETA 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.240182\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.738\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.138194476\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARRB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEPTIN 4 (PEANUT-LIKE PROTEIN 2) (BRAIN PROTEIN H5) (CELL DIVISION CONTROL-RELATED PROTEIN 2) (HCDCREL-2) (BRADEION BETA) (CE5B3 BETA) (CEREBRAL PROTEIN-7) (HUCEP-7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.16041\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.17491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.136529607\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEPT4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0210454\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336712\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS3ST4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPARAN SULFATE D-GLUCOSAMINYL  3-O-SULFOTRANSFERASE 2; HEPARIN-GLUCOSAMINE 3-O-SULFOTRANSFERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0207502\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.153323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336512\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS3ST2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3A1; HEPARIN-GLUCOSAMINE 3-O-SULFOTRANSFERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.026835\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.198284\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336184\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS3ST3A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRNA DECAPPING ENZYME; HISTIDINE TRIAD PROTEIN MEMBER 5; HEAT SHOCK-LIKE PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.279017\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.06166\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DCPS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3B1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0225884\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.166906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336057\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS3ST3B1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C439A6.1 (NOVEL PROTEIN SIMILAR TO HEPARAN SULFATE (GLUCOSAMINE) 3-O- SULFOTRANSFERASES) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0210051\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155207\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135336035\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS3ST6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RING FINGER PROTEIN 25 (EC 6.3.2.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.22015\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.62938\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135112742\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RNF25\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OLIGOSACCHARYL TRANSFERASE STT3 SUBUNIT HOMOLOG (B5) (INTEGRAL MEMBRANE PROTEIN 1) (TMC). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0284601\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.210671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135092633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STT3A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SOURCE OF IMMUNODOMINANT MHC-ASSOCIATED PEPTIDES; HOMOLOG OF YEAST STT3 GENE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0366899\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.271591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135092474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STT3B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE 48 KDA SUBUNIT PRECURSOR (EC 2.4.1.119) (OLIGOSACCHARYL TRANSFERASE 48 KDA SUBUNIT) (DDOST 48 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0217044\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.160664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.135091869\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DDOST\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
APG3P; PC3-96 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.206188\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.59883\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.128961803\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATG3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GABA-A RECEPTOR-ASSOCIATED PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0506272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.392576\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.128961526\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.170944\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.33704\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.12785257\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C1orf164\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCOGEN [STARCH] SYNTHASE, LIVER (EC 2.4.1.11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.129726\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.02722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.126288429\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GYS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ENDO-BETA-N-ACETYLGLUCOSAMINIDASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0444453\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.352603\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.126049126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCOGEN [STARCH] SYNTHASE, MUSCLE (EC 2.4.1.11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.158067\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.25601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.12584852\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GYS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COATOMER ALPHA SUBUNIT (ALPHA-COAT PROTEIN) (ALPHA-COP) (HEPCOP) (HEP-COP) [CONTAINS: XENIN (XENOPSIN-RELATED PEPTIDE); PROXENIN]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.329852\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.63087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.125377537\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COPA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.136179\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.08705\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.125273906\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEPT11\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots

- http://analysis.yellowcouch.org/